Daily news on healthcare and wellness in Italy

Provided by AGP

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
May. 7, 2026

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute

GlobeNewswire, Inc.

VCD Medical Appoints Renowned Commercial and Vascular Leader  Denna Babul as General Manager, U.S.
May. 7, 2026

VCD Medical Appoints Renowned Commercial and Vascular Leader Denna Babul as General Manager, U.S.

GlobeNewswire, Inc.

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
May. 7, 2026

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy

GlobeNewswire, Inc.

Beyond the Base: Soccer Match Unites NSA Naples, Italian Community
May. 7, 2026

Beyond the Base: Soccer Match Unites NSA Naples, Italian Community

DVIDS - Georgia

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
May. 7, 2026

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

GlobeNewswire, Inc.

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
May. 7, 2026

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

GlobeNewswire, Inc.

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
May. 7, 2026

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

GlobeNewswire, Inc.

Senegal, US and allied medical teams conclude multinational medical readiness exercise during African Lion 26
May. 6, 2026

Senegal, US and allied medical teams conclude multinational medical readiness exercise during African Lion 26

DVIDS - Georgia

Global RNA Targeting Small Molecule Drug Discovery Market Size/Share Worth USD 17.6 Billion by 2035 at a 22.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
May. 6, 2026

Global RNA Targeting Small Molecule Drug Discovery Market Size/Share Worth USD 17.6 Billion by 2035 at a 22.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

GlobeNewswire, Inc.

[Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research
May. 6, 2026

[Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research

GlobeNewswire, Inc.

Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma
4 hours ago

Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma

GlobeNewswire, Inc.

[Latest] Digestive Health Supplements Market Size Expected to Reach USD 25.86 Billion by 2034 With 6.10% CAGR, Driven by Rising Geriatric Population Worldwide and Increasing Prevalence of Digestive Health Concerns
May. 5, 2026

[Latest] Digestive Health Supplements Market Size Expected to Reach USD 25.86 Billion by 2034 With 6.10% CAGR, Driven by Rising Geriatric Population Worldwide and Increasing Prevalence of Digestive Health Concerns

GlobeNewswire, Inc.

US, Senegal multinational medical teams strengthen readiness through ingenuity
May. 5, 2026

US, Senegal multinational medical teams strengthen readiness through ingenuity

DVIDS - Georgia

U.S. Naval Hospital Naples Earns Top Defense Health Agency Award for High Reliability Excellence
May. 5, 2026

U.S. Naval Hospital Naples Earns Top Defense Health Agency Award for High Reliability Excellence

DVIDS - Georgia

[Latest] Global Surgical Case Carts Market Size/Share Worth USD 686.99 Million by 2035 at a 4.04% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
6 hours ago

[Latest] Global Surgical Case Carts Market Size/Share Worth USD 686.99 Million by 2035 at a 4.04% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire, Inc.

Global Environmental Health and Safety Software Market Size/Share Worth USD 14.52 Billion by 2035 at a 7.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
May. 5, 2026

Global Environmental Health and Safety Software Market Size/Share Worth USD 14.52 Billion by 2035 at a 7.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

GlobeNewswire, Inc.

[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
May. 4, 2026

[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire, Inc.

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
May. 4, 2026

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight

GlobeNewswire, Inc.

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
May. 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

GlobeNewswire, Inc.

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
May. 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

GlobeNewswire, Inc.

Sign up for:

Health Watch Italy

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share us

on your social networks: